Prometheus Biosciences, Inc. - stock earnings
Stock symbol RXDX is outdated, potentially delisted? Maybe it is available on other exchange?
RXDX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q4 | -38.8 million USD | 653000 USD |
| 2022Q3 | -37.3 million USD | 968000 USD |
| 2022Q2 | -33.6 million USD | 1.3 million USD |
| 2022Q1 | -32.1 million USD | 3.9 million USD |
| 2021Q4 | -29.9 million USD | 1.0 million USD |
| 2021Q3 | -27.3 million USD | 1.0 million USD |
| 2021Q2 | -19.0 million USD | 326000 USD |
| 2021Q1 | -13.9 million USD | 760000 USD |
| 2020Q3 | -6.9 million USD | 359000 USD |
RXDX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -141.8 million USD | 6.8 million USD |
| 2021 | -90.2 million USD | 3.1 million USD |
| 2020 | -37.1 million USD | 1.2 million USD |
| 2019 | -29.7 million USD | 1.1 million USD |
| 2018 | -6.8 million USD | ? USD |
RXDX
Price: $199.92
52 week price:
Earnings Per Share: -4.51 USD
P/E Ratio: -9.98
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 221500
Ebitda: -119.1 millionMarket Capitalization: 9.3 billion